Precutting endoscopic band ligation-assisted resection versus endoscopic submucosal dissection in patients with small gastric submucosal tumors originating from the muscularis propria: study protocol of a randomized controlled trial

Mingfeng Liu,Rui Yuan,Ke Zhan,Yichun Yang,Shan Li and Liang Deng
DOI: https://doi.org/10.1186/s13063-024-07902-7
IF: 2.728
2024-01-14
Trials
Abstract:The management of small gastric submucosal tumors (SMTs) originating from the muscularis propria layer (SMT-MPs) remains a subject of debate. Endoscopic submucosal dissection (ESD) is currently considered the optimal treatment for resection. However, high expenses, complex procedures, and the risk of complications have limited its application. Our previously proposed novel operation, precutting endoscopic band ligation (precutting EBL), has been demonstrated in a long-term, single-arm study to be an effective and safe technique for removing small gastric SMTs. However, the absence of a pathological examination and the potential for delayed perforation have raised concerns. Thus, we modified the precutting EBL by adding endoscopic resection to the snare after ligation and closure, yielding the precutting endoscopic band ligation-assisted resection (precutting EBLR). Moreover, the initial pilot study confirmed the safety and efficacy of the proposed approach and we planned a randomized controlled trial (RCT) to further validate its clinical feasibility.
medicine, research & experimental
What problem does this paper attempt to address?
### Problems the Paper Aims to Solve This paper aims to validate a new endoscopic surgical method—precutting endoscopic band ligation-assisted resection (precutting EBLR)—for the treatment of small gastric submucosal tumors originating from the muscularis propria (SMT-MPs). #### Background and Research Motivation Small gastric SMT-MPs (diameter less than 2 cm) are usually discovered incidentally during endoscopic examinations and are asymptomatic. However, studies have shown that approximately 60-70% of small gastric SMT-MPs are pathologically diagnosed as gastrointestinal stromal tumors (GISTs), which may have malignant potential regardless of their size. Currently, endoscopic submucosal dissection (ESD) is considered the optimal treatment method, but its high cost, complex procedure, and risk of complications limit its application. The previously proposed precutting endoscopic band ligation (precutting EBL) has been proven to be an effective and safe method, but due to the lack of pathological specimen collection and the risk of delayed perforation, further improvement is needed. #### Introduction of the New Method To overcome the shortcomings of precutting endoscopic band ligation, researchers have proposed an improved method—precutting endoscopic band ligation-assisted resection (precutting EBLR). This method involves immediate endoscopic resection after band ligation and closure of the perforation with titanium clips. Preliminary studies have shown that this method is safe and effective, and thus a randomized controlled trial (RCT) is planned to further validate its clinical feasibility. #### Study Design and Objectives This study is a single-center, open-label, parallel-group randomized controlled trial, primarily aimed at validating the effectiveness and safety of precutting endoscopic band ligation-assisted resection in managing small gastric SMT-MPs. The trial began on December 1, 2022, and is expected to enroll approximately 40 patients, divided into two groups: the ESD group and the precutting EBLR group. The primary outcome measure is the operation time, while secondary outcomes include total surgical cost, hospital stay duration, intraoperative adverse events, and postoperative recurrence. #### Conclusion By comparing the operation time and other related indicators of the two surgical methods, this study aims to validate the effectiveness and safety of precutting endoscopic band ligation-assisted resection as an innovative and promising endoscopic surgical method, providing a more practical, simple, and safe option for the treatment of small gastric SMT-MPs.